100% Tariff Proposal on Pharma Imports Sparks Policy Debate in India

The ongoing discussion around imposing 100% tariffs on pharmaceutical imports has triggered strong debate within India’s healthcare and business circles. Supporters argue that such a move could boost domestic manufacturing, encourage self-reliance, and reduce dependence on foreign supply chains, particularly in critical medicines. However, concerns remain that steep tariffs may raise input costs, disrupt availability of essential drugs, and strain patients with higher treatment expenses. The policy is still at a discussion stage, but its outcome will be significant for the pharma industry, healthcare affordability, and India’s positioning as both a major producer and consumer of pharmaceutical products. Disclaimer: Investments in securities are subject to market risk. This is for educational purposes ***** must verify information before investing and consider their financial position & risk profile. please read full disclosure disclaimer in given link